Incidental venous thromboembolism: Is anticoagulation indicated?

Hematology

Volumn 2017, Issue 1, 2017, Pages 121-127

  Di Nisio, Marcello ^a,b   Carrier, Marc ^c  

^a UNIVERSITY OF CHIETI   (Italy)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTIVITAMIN K; FONDAPARINUX; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ANTICOAGULANT THERAPY; ANTICOAGULATION; ARTICLE; BLEEDING; CANCER PATIENT; DEEP VEIN THROMBOSIS; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; ECHOGRAPHY; HUMAN; INCIDENTAL FINDING; LUNG EMBOLISM; MEDICAL DECISION MAKING; META ANALYSIS (TOPIC); PATIENT PREFERENCE; PREVALENCE; PROGNOSIS; PULMONARY ARTERY; RADIODIAGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENT DISEASE; RISK BENEFIT ANALYSIS; RISK FACTOR; SCREENING; SPLANCHNIC VEIN THROMBOSIS; TREATMENT DURATION; VENOUS THROMBOEMBOLISM; WATCHFUL WAITING; X-RAY COMPUTED TOMOGRAPHY; NEOPLASM; VEIN THROMBOSIS;

ANTICOAGULANTS; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; NEOPLASMS; PULMONARY EMBOLISM; VENOUS THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 85038414583     PISSN: 15204391     EISSN: 15204383     Source Type: Journal    
DOI: 10.1182/asheducation-2017.1.121     Document Type: Article

References (58)

1. Timp JF, Braekkan SK, Versteeg HH, Cannegieter SC. Epidemiology of cancer-associated venous thrombosis. Blood. 2013;122(10):1712-1723.
2. van Es N, Bleker SM, Di Nisio M. Cancer-associated unsuspected pulmonary embolism. Thromb Res. 2014;133(Suppl 2):S172-S178.
3. Bach AG, Schmoll H-J, Beckel C, et al. Pulmonary embolism in oncologic patients: Frequency and embolus burden of symptomatic and unsuspected events. Acta Radiol. 2014;55(1):45-53.
4. O'Connell C, Razavi P, Ghalichi M, et al. Unsuspected pulmonary emboli adversely impact survival in patients with cancer undergoing routine staging multi-row detector computed tomography scanning. J Thromb Haemost. 2011;9(2):305-311.
5. Sahut D'Izarn M, Caumont Prim A, Planquette B, et al. Risk factors and clinical outcome of unsuspected pulmonary embolism in cancer patients: A case-control study. J Thromb Haemost. 2012;10(10):2032-2038.
6. Connolly GC, Menapace L, Safadjou S, Francis CW, Khorana AA. Prevalence and clinical significance of incidental and clinically suspected venous thromboembolism in lung cancer patients. Clin Lung Cancer. 2013;14(6):713-718.
7. Khorana AA, O'Connell C, Agnelli G, Liebman HA, Lee AY; Subcommittee on Hemostasis and Malignancy of the SSC of the ISTH. Incidental venous thromboembolism in oncology patients. J Thromb Haemost. 2012;10(12):2602-2604.
8. Farrell C, Jones M, Girvin F, Ritchie G, Murchison JT. Unsuspected pulmonary embolism identified using multidetector computed tomography in hospital outpatients. Clin Radiol. 2010;65(1):1-5.
9. Browne AM, Cronin CG, English C, NiMhuircheartaigh J, Murphy JM, Bruzzi JF. Unsuspected pulmonary emboli in oncology patients undergoing routine computed tomography imaging. J Thorac Oncol. 2010; 5(6):798-803.
10. Menapace LA, Peterson DR, Berry A, Sousou T, Khorana AA. Symptomatic and incidental thromboembolismare both associatedwith mortality in pancreatic cancer. Thromb Haemost. 2011;106(2):371-378.
11. Shinagare AB, Guo M, Hatabu H, et al. Incidence of pulmonary embolism in oncologic outpatients at a tertiary cancer center. Cancer. 2011;117(16):3860-3866.
12. Callejas MF, Errázuriz JI, Castillo F, et al. Incidental venous thromboembolism detected by PET-CT in patients with cancer: Prevalence and impact on survival rate. Thromb Res. 2014;133(5):750-755.
13. Singh R, Sousou T, Mohile S, Khorana AA. High rates of symptomatic and incidental thromboembolic events in gastrointestinal cancer patients. J Thromb Haemost. 2010;8(8):1879-1881.
14. Tiseo M, Bersanelli M, Pesenti Barili M, et al. Asymptomatic pulmonary embolism in lung cancer: Prevalence and analysis of clinical and radiological characteristics in 141 outpatients. Tumori. 2012;98(5): 594-600.
15. Tresoldi S, Flor N, Luciani A, Lombardi MA, Colombo B, Cornalba G. Contrast enhanced chest-MDCT in oncologic patients. Prospective evaluation of the prevalence of incidental pulmonary embolism and added value of thin reconstructions. Eur Radiol. 2015;25(11):3200-3206.
16. den Exter PL, van der Hulle T, Hartmann IJC, et al. Reliability of diagnosing incidental pulmonary embolism in cancer patients. Thromb Res. 2015;136(3):531-534.
17. Bleker SM, Beenen LF, Di Nisio M, et al. Incidental pulmonary embolism in cancer patients: Interobserver agreement on the diagnosis and extent with a focus on distal clots. Thromb Res. 2016;147:46-51.
18. AgenoW, Dentali F, Squizzato A. How I treat splanchnic vein thrombosis. Blood. 2014;124(25):3685-3691.
19. Ageno W, Riva N, Schulman S, et al. Long-term clinical outcomes of splanchnic vein thrombosis: Results of an international registry. JAMA Intern Med. 2015;175(9):1474-1480.
20. Riva N, AgenoW, Schulman S, et al; International Registry on Splanchnic Vein Thrombosis (IRSVT) study group. Clinical history and antithrombotic treatment of incidentally detected splanchnic vein thrombosis: A multicentre, international prospective registry. Lancet Haematol. 2016;3(6):e267-e275.
21. Bozas G, Ramasamy S, Avery G, Maraveyas A. Unsuspected visceral venous thrombosis, in patients with cancer of the gastrointestinal system. Thromb Res. 2012;130(4):682-684.
22. den Exter PL, Kroft LJ, van der Hulle T, Klok FA, Jiménez D, Huisman MV. Embolic burden of incidental pulmonary embolism diagnosed on routinely performed contrast-enhanced CT-imaging in cancer patients. J Thromb Haemost. 2013;11(8):1620-1622.
23. den Exter PL, Hooijer J, Dekkers OM, Huisman MV. Risk of recurrent venous thromboembolism and mortality in patients with cancer incidentally diagnosed with pulmonary embolism: A comparison with symptomatic patients. J Clin Oncol. 2011;29(17):2405-2409.
24. Font C, Farrús B, Vidal L, et al. Incidental versus symptomatic venous thrombosis in cancer: A prospective observational study of 340 consecutive patients. Ann Oncol. 2011;22(9):2101-2106.
25. Larsen AC, Brøndum Frøkjaer J, Wishwanath Iyer V, et al. Venous thrombosis in pancreaticobiliary tract cancer: Outcome and prognostic factors. J Thromb Haemost. 2015;13(4):555-562.
26. Shinagare AB, Okajima Y, Oxnard GR, et al. Unsuspected pulmonary embolism in lung cancer patients: Comparison of clinical characteristics and outcome with suspected pulmonary embolism. Lung Cancer. 2012; 78(2):161-166.
27. CarrierM, Righini M, Wells PS, et al. Subsegmental pulmonary embolism diagnosed by computed tomography: Incidence and clinical implications.A systematic review and meta-analysis of the management outcome studies. J Thromb Haemost. 2010;8(8):1716-1722.
28. den Exter PL, van Es J, Klok FA, et al. Risk profile and clinical outcome of symptomatic subsegmental acute pulmonary embolism. Blood. 2013; 122(7):1144-1149, quiz 1329.
29. Goy J, Lee J, Levine O, Chaudhry S, Crowther M. Sub-segmental pulmonary embolism in three academic teaching hospitals: A review of management and outcomes. J Thromb Haemost. 2015;13(2):214-218.
30. van der Hulle T, den Exter PL, Planquette B, et al. Risk of recurrent venous thromboembolism and major hemorrhage in cancer-associated incidental pulmonary embolism among treated and untreated patients: A pooled analysis of 926 patients. J Thromb Haemost. 2016;14(1): 105-113.
31. Olmos VP, Adrian SG, Podesta MC, et al. Splanchnic vein thrombosis in ambulatory pancreatic cancer patients receiving chemotherapy [published online ahead of print]. J Clin Oncol. doi:10.1200/jco.2015.33.15-suppl. e20658.
32. Khorana AA, Rubens D, Francis CW. Screening high-risk cancer patients for VTE: A prospective observational study. Thromb Res. 2014;134(6): 1205-1207.
33. Kitayama H, Tsuji Y, Sugiyama J, Kondo T, Hirayama M. Venous thromboembolism in hospitalized cancer patients receiving chemotherapy in Japan: A prospective observational study. Ann Oncol. 2015;26: 116.
34. Lyman GH, Khorana AA, Kuderer NM, et al; American Society of Clinical Oncology Clinical Practice. Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2013; 31(17):2189-2204.
35. Di Nisio M, Lee AYY, Carrier M, Liebman HA, Khorana AA; Subcommittee on Haemostasis and Malignancy. Diagnosis and treatment of incidental venous thromboembolism in cancer patients: Guidance from the SSC of the ISTH. J Thromb Haemost. 2015;13(5):880-883.
36. Amato B, Compagna R, Rocca A, et al. Fondaparinux vs warfarin for the treatment of unsuspected pulmonary embolism in cancer patients. Drug Des Devel Ther. 2016;10:2041-2046.
37. Peris M, Jiménez D, Maestre A, et al; RIETE Investigators. Outcome during and after anticoagulant therapy in cancer patients with incidentally found pulmonary embolism. Eur Respir J. 2016;48(5):1360-1368.
38. Donato AA, Khoche S, Santora J, Wagner B. Clinical outcomes in patients with isolated subsegmental pulmonary emboli diagnosed by multidetector CT pulmonary angiography. Thromb Res. 2010;126(4): E266-e270.
39. den Exter PL, van Roosmalen MJG, van den Hoven P, et al. Physicians' management approach to an incidental pulmonary embolism: An international survey. J Thromb Haemost. 2013;11(1):208-213.
40. Carrier M, Kimpton M, LE Gal G, et al. The management of a subsegmental pulmonary embolism: A cross-sectional survey of Canadian thrombosis physicians. J Thromb Haemost. 2011;9(7):1412-1415.
41. Lim WY, Bozas G, Noble S, Hart S, Maraveyas A. Anticoagulating the subsegmental pulmonary embolism in cancer patients: A survey amongst different medical specialties. J Thromb Thrombolysis. 2015;40(1):37-41.
42. Galanaud J-P, Sevestre M-A, Pernod G, et al. Long-term outcomes of cancer-related isolated distal deep vein thrombosis: The OPTIMEV study. J Thromb Haemost. 2017;15(5):907-916.
43. Dentali F, Pegoraro S, Barco S, et al. Clinical course of isolated distal deep vein thrombosis in patients with active cancer: A multicenter cohortstudy [published online ahead of print 21 June 2017]. J Thromb Haemost.
44. Escalante CP, Gladish GW, Qiao W, et al. Prospective cohort study of cancer patients diagnosed with incidental venous thromboembolism on routine computed tomography scans. Support Care Cancer. 2017;25(5): 1571-1577.
45. Gosselin MV, Rubin GD, Leung AN, Huang J, Rizk NW. Unsuspected pulmonary embolism: Prospective detection on routine helical CT scans. Radiology. 1998;208(1):209-215.
46. Boswell WD, Pierce J, Fahimi A, Parisky Y, Sheth P. Incidental pulmonary emboli detected by multi-detector row spiral CT in cancer patients. Cancer Imaging. 2004;5:1-7.
47. Storto ML, Di Credico A, Guido F, Larici AR, Bonomo L. Incidental detection of pulmonary emboli on routine MDCT of the chest. AJR Am J Roentgenol. 2005;184(1):264-267.
48. Sebastian AJ, Paddon AJ. Clinically unsuspected pulmonary embolism- an important secondary finding in oncology CT. Clin Radiol. 2006;61(1): 81-85.
49. Gladish GW, Choe DH, Marom EM, Sabloff BS, Broemeling LD, Munden RF. Incidental pulmonary emboli in oncology patients: Prevalence, CT evaluation, and natural history. Radiology. 2006;240(1): 246-255.
50. Cronin CG, Lohan DG, Keane M, Roche C, Murphy JM. Prevalence and significance of asymptomatic venous thromboembolic disease found on oncologic staging CT. AJR Am J Roentgenol. 2007;189(1):162-170.
51. Rita Larici A, Calandriello L, Maggi F, Torge M, Bonomo L. Prevalence of incidental pulmonary emboli in oncology patients. Radiology. 2007; 245(3):921-922, author reply 921-922.
52. Ritchie G, McGurk S, McCreath C, Graham C, Murchison JT. Prospective evaluation of unsuspected pulmonary embolism on contrast enhanced multidetector CT (MDCT) scanning. Thorax. 2007;62(6): 536-540.
53. Hui GC, Legasto A, Wittram C. The prevalence of symptomatic and coincidental pulmonary embolism on computed tomography. J Comput Assist Tomogr. 2008;32(5):783-787.
54. Sun J-M, Kim TS, Lee J, et al. Unsuspected pulmonary emboli in lung cancer patients: The impact on survival and the significance of anticoagulation therapy. Lung Cancer. 2010;69(3):330-336.
55. Di Nisio M, Ferrante N, De Tursi M, et al. Incidental venous thromboembolism in ambulatory cancer patients receiving chemotherapy. Thromb Haemost. 2010;104(5):1049-1054.
56. Chaturvedi S, Sidana S, Elson P, Khorana AA, McCrae KR. Symptomatic and incidental venous thromboembolic disease are both associated with mortality in patients with prostate cancer. PLoS One. 2014; 9(8):e94048. doi: 10.1371/journal.pone.0094048. eCollection 2014.
57. Douma RA, Kok MGM, Verberne LM, Kamphuisen PW, Büller HR. Incidental venous thromboembolism in cancer patients: Prevalence and consequence. Thromb Res. 2010;125(6):e306-e309.
58. Ageno W, Squizzato A, Togna A, et al. Incidental diagnosis of a deep vein thrombosis in consecutive patients undergoing a computed tomography scan of the abdomen: A retrospective cohort study. J Thromb Haemost. 2012;10(1):158-160.